Rubicon Genomics

Rubicon Genomics was founded in 2000 by two University of Michigan faculty members, Dr. John Langmore and Dr. Vladimir Makarov, who wanted to advance the translation of human genetics “laboratory knowledge” into practical medical applications. The founders also decided to maintain the company’s roots in Michigan with a commitment to supporting the Michigan economy. Today, Rubicon Genomics is a privately held company located in Ann Arbor, Michigan. Our innovative products combined with our strategic partnerships have established the company as a leader in pre-analytical amplification technologies. Our core competencies, including enzymology, nucleic acid chemistry, sample processing and manufacturing, have served as engines for innovation, development of intellectual property, and ongoing product development. Our partnership with the academic community and our customers has fueled our engine, resulting in a robust pipeline of future products. Our products "break the sample barriers" for our customers allowing use of less sample from a diverse set of sample sources. Each of our kits is constructed for ease of use, robustness, and speed to results. RGI products are available for research use and can be purchased direct, through our distributors or OEM partners.
Ann Arbor, US
34 (est)-5%

Rubicon Genomics Locations

Ann Arbor, US

Rubicon Genomics Metrics

Rubicon Genomics Summary

Founding Date


Total Funding

$5.5 M

Latest funding size

$2 M

Time since last funding

over 1 year


Rubicon Genomics News

Rubicon Genomics Company Life

You may also be interested in